Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 4/20 | 0.41 |
| ▸ | PI4K2B | Q8TCG2 | 4/20 | 0.41 |
| ▸ | PI4K2A | Q9BTU6 | 4/20 | 0.41 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.41 |
| ▸ | XDH | P47989 | 2/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.35 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.33 |
| ▸ | AHCY | P23526 | 3/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
| ▸ | MTAP | Q13126 | 1/20 | 0.30 |
| ▸ | PNP | P00491 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL20485928 | 0.92 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL385841 | 0.90 | PI4KA (0.45) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL3416954 | 0.90 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL3413247 | 0.90 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL3414603 | 0.90 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL8110 | 0.90 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL1871837 | 0.88 | PI4KA (0.44) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL691914 | 0.88 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL5601016 | 0.88 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL11798390 | 0.88 | PI4KA (0.50) | PI4KAPI4K2BPI4K2API4KBXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684382-A | Preparation method of long-chain oligonucleotide | 苏州欧利生物医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| WO-2024006672-A2 | MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING | UNIVERSITY OF MASSACHUSETTS (US) | 2024-01-04 | — | — | WO | disclosed |
| CN-115666659-A | Synthesis of modified oligonucleotides with increased stability | 马萨诸塞大学 | 2023-01-31 | — | — | CN | disclosed |
| US-20170003289-A1 | METHODS AND MATERIALS FOR ASSESSING ENZYME-NUCLEIC ACID COMPLEXES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2017-01-05 | — | — | US | disclosed |
| US-20100273681-A1 | COMBINATORIAL CHEMISTRY REACTION CELL WITH OPTICAL TWEEZERS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-10-28 | — | — | US | disclosed |
| US-20060008907-A1 | Control of gene expression via light activated RNA interference | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2006-01-12 | — | — | US | disclosed |
| US-6855501-B2 | Transfer of arrayed chemical compositions | LINDEN TECHNOLOGIES, INC. (US) | 2005-02-15 | — | — | US | disclosed |
| EP-1154857-A4 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR AUTOMATED FLUID OR GAS DELIVERY | INVITROGEN CORP (US) | 2005-01-19 | — | — | EP | disclosed |
| US-6838447-B2 | Particulate compositions for chemical synthesis | LINDEN TECHNOLOGIES, INC. (US) | 2005-01-04 | — | — | US | disclosed |
| EP-0791238-B1 | LIQUID DISTRIBUTION SYSTEM | ORCHID BIOSCIENCES INC (US) | 2004-09-22 | — | — | EP | disclosed |
| US-20020136772-A1 | Polymer synthesis | LINDEN TECHNOLOGIES, INC. | 2002-09-26 | — | — | US | disclosed |
| EP-1154857-A1 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR AUTOMATED FLUID OR GAS DELIVERY | INVITROGEN CORPORATION (US) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000045957-A1 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR AUTOMATED FLUID OR GAS DELIVERY | INVITROGEN CORPORATION (US) | 2000-08-10 | — | — | WO | disclosed |
| US-6033544-A | Liquid distribution system | SARNOFF CORPORATION (US) | 2000-03-07 | — | — | US | disclosed |
| US-5958344-A | System for liquid distribution | SARNOFF CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| US-5846396-A | Liquid distribution system | SARNOFF CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0791238-A4 | LIQUID DISTRIBUTION SYSTEM | SARNOFF DAVID RES CENTER (US) | 1998-09-02 | — | — | EP | disclosed |
| EP-0791238-A1 | LIQUID DISTRIBUTION SYSTEM | Sarnoff Corporation (US) | 1997-08-27 | — | — | EP | disclosed |
| WO-1996015576-A9 | LIQUID DISTRIBUTION SYSTEM | — | 1996-08-29 | — | — | WO | disclosed |
| WO-1996015576-A1 | LIQUID DISTRIBUTION SYSTEM | DAVID SARNOFF RESEARCH CENTER, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170003289-A1 | METHODS AND MATERIALS FOR ASSESSING ENZYME-NUCLEIC ACID COMPLEXES | RNGTT, DNASE1, POLRMT | PI4KA 4095/4885PI4K2B 4111/4885PI4K2A 3887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.